New criteria for Alzheimer's diagnosis allows for preclinical treatment

10/12/2010 | Yahoo!

International Alzheimer's disease experts are suggesting that patients who have episodic memory impairment along with at least one positive biomarker be diagnosed with the disease. The new criteria for diagnosis would allow more patients to get treatment or qualify for clinical trials. "There is no longer a reason to wait until patients have developed full-blown dementia," said Bruno Dubois, leader of the International Working Group for New Research Criteria for the Diagnosis of Alzheimer's Disease.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT